Privia Health updated its full-year 2023 guidance, as follows:
| FY 2022 | Initial FY 2023 Guidance at 2.28.23 a | Current FY 2023 Guidance 11.3.23 | |||||||||||
| ($ in millions) | Actual | Low | High | ||||||||||
| Implemented Providers | 3,606 | 4,050 | 4,150 | Above High End | |||||||||
| Attributed Lives | 856,000 | 1,050,000 | 1,150,000 | Midpoint | |||||||||
| Practice Collections | $ | 2,424.1 | $ | 2,700 | $ | 2,850 | Midpoint | ||||||
| GAAP Revenue | $ | 1,356.7 | $ | 1,550 | $ | 1,650 | Mid to High End | ||||||
| Care Margin | $ | 305.6 | $ | 350 | $ | 365 | Mid to High End | ||||||
| Platform Contribution | $ | 148.5 | $ | 160 | $ | 168 | Above High End | ||||||
| Adjusted EBITDAc | $ | 60.9 | $ | 70 | $ | 74 | Mid to High End | ||||||
- Practice Collections guidance includes impact of paused capitated agreement previously announced
- Adjusted EBITDA guidance includes approximately $10 million in start-up costs for new geographies and ACOs, and higher than initially forecasted sales and marketing costs due to record in-market sales
- Capital expenditures expected to be less than $1 million in full-year 2023
- Approximately 80-90% of Adjusted EBITDA expected to convert to free cash flow (defined as net cash provided by operating activities less capital expenditures) in FY 2023
The Company will host a conference call on November 3, 2023, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. If you wish to participate in the live conference call, then please go to https://register.vevent.com/register/BI93f79e2535cf432ab5d86149b9f61609 to pre-register and obtain your dial-in number and passcode.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.